SNPMiner Trials by Shray Alag


SNPMiner SNPMiner Trials (Home Page)


Report for SNP rs112735431

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

There is one clinical trial.

Clinical Trials


1 Prevalence of Genetic Polymporphism on RNF213 rs112735431 Gene in Non-cardioemboli Ischemic Cerebrovascular Disease: A Cross-sectional Study in Thai Patients

To explore the prevalence of genetic polymorphism on RNF213 rs112735431 gene in non-cardioembolic ischemic cerebrovascular disease in Thai patients.

NCT02720861 Ischemic Stroke Genetic: DNA sequencing
MeSH: Cerebrovascular Disorders Ischemia

Prevalence of Genetic Polymporphism on RNF213 rs112735431 Gene in Non-cardioemboli Ischemic Cerebrovascular Disease: A Cross-sectional Study in Thai Patients.

Prevalence of Genetic Polymporphism on RNF213 rs112735431 Gene in Non-cardioemboli Ischemic Cerebrovascular Disease To explore the prevalence of genetic polymorphism on RNF213 rs112735431 gene in non-cardioembolic ischemic cerebrovascular disease in Thai patients.

Number of Participants With RNF213 rs112735431 Gene polymorphism.

Inclusion Criteria: - Nationality in Thailand - Age equal or more than 18 years - Clinical and imaging diagnosis of acute ischemic stroke - Patient consent to participate in the research Exclusion Criteria: - High risk for cardioembolic stroke by TOAST classification - Contraindication for venipuncture - Pregnancy or breast feeding patient - History of head and neck radiation - Down's syndrome - Marfan syndrome - Autoimmune disease such as SLE - Ongoing malignancy or remission of malignancy less than 1year Inclusion Criteria: - Nationality in Thailand - Age equal or more than 18 years - Clinical and imaging diagnosis of acute ischemic stroke - Patient consent to participate in the research Exclusion Criteria: - High risk for cardioembolic stroke by TOAST classification - Contraindication for venipuncture - Pregnancy or breast feeding patient - History of head and neck radiation - Down's syndrome - Marfan syndrome - Autoimmune disease such as SLE - Ongoing malignancy or remission of malignancy less than 1year Ischemic Stroke Cerebrovascular Disorders Ischemia This is an cross-sectional observational study in Chulalongkorn hospital, to determine the prevalence of genetic polymorphism on RNF213 rs112735431 gene in non-cardioembolic ischemic cerebrovascular disease.

Primary Outcomes

Measure: Number of Participants With RNF213 rs112735431 Gene polymorphism

Time: 1 year


HPO Nodes